Li Ning, Klaassen Curtis D
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
Mol Pharmacol. 2004 Sep;66(3):694-701. doi: 10.1124/mol.66.3..
Lipopolysaccharide (LPS) administration is a model of cholestasis. Organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is almost exclusively expressed in liver. Therefore, it was hypothesized that LPS would down-regulate mouse Oatp4 and that this action is due to a decrease in nuclear binding activity of one or more liver-enriched transcription factors to mouse Oatp4 promoter. The present study indicates a time-dependent decrease in mouse Oatp4 mRNA levels by LPS. Moreover, LPS produced a rapid and profound decrease in nuclear binding activity to the mouse Oatp4 putative response elements for hepatocyte nuclear factor (HNF) 1, CAAT/enhancer binding protein (C/EBP), HNF3, and heterodimers of retinoid X receptor (RXR) and retinoic acid receptor (RAR). Maximal decrease in nuclear binding activity to these response elements preceded a significant reduction of Oatp4 mRNA levels. HNF1alpha bound to the Oatp4 HNF1 response element as a homodimer. Multiple copies of the Oatp4 HNF1alpha response element, inserted upstream of a minimal promoter, were sufficient to mediate reporter activity and responded to the coexpression of HNF1alpha in mouse hepatoma cells. Moreover, HNF1alpha dose dependently activated the Oatp4 promoter (-4.8 kilo-bases to +30 bp). Therefore, HNF1alpha is a potent trans-activator of the mouse Oatp4 promoter. In addition, Oatp4 mRNA levels were markedly decreased (95%) in HNF1alpha-null mice as compared with wild-type mice, suggesting that HNF1alpha levels are critical for the constitutive expression of the Oatp4 gene. Taken together, these findings suggest that the LPS-induced down-regulation of Oatp4 is likely due to reduction in the binding of HNF1alpha, C/EBP, HNF3, and RXR:RAR to the Oatp4 promoter.
给予脂多糖(LPS)是胆汁淤积的一种模型。有机阴离子转运多肽4(Oatp4;Slc21a10)几乎仅在肝脏中表达。因此,有人推测LPS会下调小鼠Oatp4,且这种作用是由于一种或多种肝脏富集转录因子与小鼠Oatp4启动子的核结合活性降低所致。本研究表明LPS可使小鼠Oatp4 mRNA水平呈时间依赖性下降。此外,LPS使与小鼠Oatp4假定反应元件结合的核结合活性迅速且显著下降,这些反应元件针对肝细胞核因子(HNF)1、CCAAT/增强子结合蛋白(C/EBP)、HNF3以及视黄酸X受体(RXR)和视黄酸受体(RAR)的异二聚体。这些反应元件的核结合活性最大程度下降先于Oatp4 mRNA水平的显著降低。HNF1α以同二聚体形式与Oatp4 HNF1反应元件结合。插入最小启动子上游的多个Oatp4 HNF1α反应元件拷贝足以介导报告基因活性,并对小鼠肝癌细胞中HNF1α的共表达产生反应。此外,HNF1α剂量依赖性地激活Oatp4启动子(-4.8千碱基至+30碱基对)。因此,HNF1α是小鼠Oatp4启动子的有效反式激活因子。此外,与野生型小鼠相比,HNF1α基因敲除小鼠的Oatp4 mRNA水平显著降低(95%),这表明HNF1α水平对于Oatp4基因的组成性表达至关重要。综上所述,这些发现表明LPS诱导的Oatp4下调可能是由于HNF1α、C/EBP、HNF3和RXR:RAR与Oatp4启动子的结合减少所致。